相关实验视频
Updated: Jun 12, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
51
青少年异常性关节炎治疗选择的演变
Tao Ren1, Jia-Hui Guan1, Yu Li2
1Department of Colorectal Surgery, Taihe County People's Hospital of Anhui Province, Fuyang 236600, Anhui Province, China.
World journal of orthopedics
|September 25, 2024
概括
非类固醇抗炎药物 (NSAID) 和葡萄糖皮质类药物可以控制青少年异常性关节炎 (JIA) 的症状,但不能预防关节损伤. 改变疾病的抗风湿药物 (DMARDs),特别是生物DMARDs (bDMARDs),正在通过防止JIA的进展来彻底改变JIA的治疗.
科学领域:
- 类风湿病学 类风湿病学
- 儿科风湿病学 儿科风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 青春期异常性关节炎 (JIA) 管理历史上一直依赖于非类固醇抗炎药物 (NSAID) 和葡萄皮质类药物来缓解症状.
- 虽然NSAIDs具有良好的耐受性,选择性选择降低了胃肠道风险,但NSAIDs和葡萄皮质类药物都不能防止JIA的关节损伤.
- 疾病修饰性抗风湿药物 (DMARDs) 是一个重大进步,具有阻止疾病进展和减轻关节破坏的潜力.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Autoimmune Disorders
395
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
395
Tonsillitis II: Management
104
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
104

